Another reason might be the increased activity of sialyltransferases that orchestrate the diversity of glycan structures and are frequently overregulated in cancer cells [45–47] and tumor microenvironment where TF-specific antibodies may interact with TF-positive tumor cells and undergo further sialylation in situ. The gene discussed is TF; the disease is neoplasm.